Introduction: Recently, the pharmacological treatment has aimed to improve cognitive deficits and behavioral and psychological symptoms of dementia. Antipsychotics are often used for excitement or hyperactivity of dementia and evaluating the efficiency of the medication has been important. We researched the tendency of choice of antidementia drugs and antipsychotics for patients with dementia.
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Improvement to antipsychotic treatment at week 2 predicts subsequent treatment response in behavioral and psychological symptoms with dementia: Analysis of the CATIE-AD data However, it still remains unclear as to which factors could serve as predictors of response to antipsychotic treatment. The aim of this study was to examine presence/absence of improvement with antipsychotics at week 2 would be associated with treatment response/non-response at week 8 in patients with BPSD. Methods: The dataset from 245 subjects (olanzapine, n=90; quetiapine, n=81; risperidone, n=74) who presented with a score of ≥1 in the Brief Psychiatric Rating Scale (BPRS) at baseline in Phase 1 of the Clinical Antipsychotic Trials in Intervention Effectiveness with Alzheimer's Disease (CATIE-AD) were used. First, demographic and clinical characteristics associated with response at week 8 were examined, using binary logistic regression analyses. Treatment response was defined as a score reduction of ≥one minimal clinically important difference (MCID) defined as a half of SD in the BPRS. Next, the prediction performance of binary classification in early improvement at week 2 (i.e. presence or absence) for response at week 8 was examined with sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Multiple imputation was employed for missing data. Results: The BPRS total score reduction at week 2 was significantly associated with subsequent response at week 8 (odds ratio, 1.17; 95% confidence interval, 1.11-1.24; p<0.05). Furthermore, the 10% cut-off at week 2 presented with the highest precision (0.67) with sensitivity, specificity, NPV, and PPV of 0.69, 0.67, 0.73, and 0.62, respectively. Conclusions: Presence or absence of early improvement at week 2 with antipsychotic treatment can be a strong predictor of subsequent response at week 8 in the treatment of BPSD. Evaluating patients early in the course of treatment with antipsychotic drugs can help identify non-responders who may benefit from alternative therapeutic approaches.
